Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Lafayette, Louisiana 14 trials found
New Search
Filter
Trial Phase
Study Type
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
PHASE2INTERVENTIONAL Lafayette, Louisiana +4 more
RECRUITING
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
PHASE3INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
PSMA PET Combined With MRI for the Detection of PCa
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Galleri® in the Medicare Population.
NAINTERVENTIONAL Fort Smith, Arkansas +4 more
RECRUITING
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
PHASE2INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
PHASE2INTERVENTIONAL Bakersfield, California +4 more
RECRUITING
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
PHASE3INTERVENTIONAL Sun City, Arizona +4 more
RECRUITING
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type